Approval · Notice of Compliance 17338 · 2015
ZERBAXA: Notice of Compliance 17338
Issued September 30, 2015
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 17338
- Date
- September 30, 2015
- Company
- Merck Canada IncKirkland, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- New Active Substance (NAS)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ZERBAXA | 02446901 | Marketed |
Medicinal ingredients
- TAZOBACTAM SODIUM 0.5 G per VIAL
- CEFTOLOZANE SULFATE 1 G per VIAL